Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from γc transduced severe combined immunodeficiency X1 bone marrow cells

Blood

Volumn 88, Issue 10, 1996, Pages 3901-3909

  Cavazzana Calvo, M ^a   Hacein Bey, S ^a   De Saint Basile, G ^a   De Coene, C ^a   Selz, F ^a   Le Deist, F ^a   Fischer, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYTOKINE RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; STEM CELL FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COMBINED IMMUNODEFICIENCY; CYTOTOXICITY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD; X CHROMOSOME LINKAGE;

EID: 0029850719     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3901.bloodjournal88103901     Document Type: Article

References (37)

1. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, Durandy A, Griscelli C, Fischer A: Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 123:564, 1993
2. Noguchi M, Yi M, Rosenblattt THM, Flilipovitch AM, Adelstein S, Modiw S, Mc Bride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993
3. Leonard WJ, Shores EW, Love PE: Role of the common cytokine receptor γ chain in cytokine signaling and lymphoid development. Immunol Rev 48:97, 1995
4. Peschon JJ, Morissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CBJD, Davidson BL: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955, 1994
5. Von Freeden-Jeffry U, Vieira P, Lucian LA, Mc Neil T, Burdach SEG, Murray R: Lymphopenia in interleukin-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181:1519, 1995
6. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 92:377, 1995
7. Schorle H, Holtschke T, Hunig T, Schimpla A, Horak J: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621, 1991
8. Kühn R, Rajewsky K, Müller W: Generation and analysis of interleukin-4 deficient mice. Science 254:707, 1991
9. DiSanto JP, Keever CA, Small TN, Nichols GL, O'Reilly RJ, Flomenberg N: Absence of interleukin-2 production in a severe combined immunodeficiency disease syndrome with T cells. J Exp Med 171:1697, 1990
10. Weinberg K, Parkman R: Severe combined immunodeficiency due to a specific defect in the production of interleukin 2. N Engl J Med 322:1718, 1990
11. + NK progenitor. Blood 83:2594, 1994
12. + hematopoietic progenitor cells. Blood 85:3538, 1995
13. Silva MGR, Hoffman R, Srour EF, Ascensao JL: Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 84:841, 1994
14. + hematopoietic progenitor cells. Blood 87:2632, 1996
15. Giri JG, Ahdieh M, Eisenman J, Shanebuck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
16. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
17. Hacein-Bey S, Cavazzana-Calvo M, Le Deist F, Dautry-Varsat A, Hivroz C, Rivière J, Danos O, Hears JM, Sugamura K, Fischer A, De Saint Basile G: γc gene transfer into SCID-X1 patients' B-cell lines restores normal high-affinity IL2 receptor expression and function, Blood 87:6108, 1996
18. Riviere I, Bros K, Mulligan RC: Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733, 1995
19. Barklis E, Mulligan RC, Jaenisch R: Chromosal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391, 1986
20. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85:6460, 1988
21. Danos O: Construction of retroviral packaging cell lines, in Collins M (ed): Methods in Molecular Biology. Clifton, NJ, Humana, 1991, p 17
22. Ishii N, Asao H, Kimura Y, Takeshita T, Nakamura M, Tsuchiya S, Konno T, Maeda M, Uchiyama T, Sugamuara K: Impairment of ligand binding and growth signaling of mutant IL-2 receptor γ-chains in patients with X-linked severe combined immunodeficiency. J Immunol 22:1310, 1994
23. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 172:1589, 1990
24. + natural killer cells: Role in cell activation and regulation of cytolytic function. J Exp Med 171:695, 1990
25. Perussia B, Trinchieri G, Cerottini JC: Functional studies of Fc receptor-bearing human lymphocytes: Effect of treatment with proteolytic enzymes. J Immunol 123:681, 1979
26. Coulombel L, Eaves AC, Eaves CI: Enzymatic treatment of long-term human marrow cultures needs the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291, 1983
27. Fogh J: Cultivation characterization and identification of human tumor cells with emphasis on kidney, testis and bladder tumors. Natl Cancer Inst Monogr 49:5, 1978
28. - progenitor cells in long-term cultures and semisolid assays. Blood 81:2916, 1993
29. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
30. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL: Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε, δ proteins. J Exp Med 175:1055, 1992
31. Düchler M, Offterdinger M, Holzmüller H, Lipp J, Chu CT, Aschaner B, Bach FH, Hofer E: NKG.2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur J Immunol 25:2923, 1995
32. Voss SD, Hong R, Sondel PM: Severe combined immunodeficiency, interleukin-2 (IL-2) and the IL-2 receptor: Experiments of nature continue to point the way. Blood 83:626, 1994
33. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Nakamura M, Takeshita T: The common γ-chain for multiple cytokine receptors. Adv Immunol 59:225, 1995
34. Lanier LL, Chang C, Spits H, Phillips JH: Expression of cytoplasmic CD3ε proteins in activated human adult natural killer (NK) cells and CD3 γ, δ, ε+ complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes. J Immunol 149:1876, 1992
35. Blaese RM, Culver KW, Miller AD, Carter CS, Fleischer T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen C, Ranisey WJ, Muni L, Morgan RA, Anderson WF: T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270:475, 1995
36. Bordignon C, Notarangelo L, Nobili N, Ferrari G, Casorati F, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470, 1995
37. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Craig A, Muller R, Blaese M, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1:1017, 1995